A scientist works in a laboratory at the Novavax facility in Gaithersburg, MD (Jon Cherry/Bloomberg via Getty Images)
FDA advisors vote 21-0, with one abstention, to authorize Novavax’s Covid-19 vaccine to be the fourth US option
A panel of FDA’s outside experts recommended 21 to 0, with one member abstaining, that the agency give emergency use authorization for Novavax’s two-dose Covid …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
